Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.405 EUR | -0.71% | -2.43% | -7.87% |
May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
May. 14 | Medigene Ag Maintains Earnings Guidance for 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
37.78M | - | |||||
114B | ||||||
104B | ||||||
22.41B | - | |||||
22.28B | - | |||||
19.07B |
- Stock Market
- Equities
- MDG1 Stock
- Charts Medigene AG
- Sector Chart